A woman is given a recombinant form of a human natriuretic peptide. Which mechanism is responsible for the cardiovascular effects of this drug?
(A) inhibition of adenylyl cyclase
(B) stimulation of adenylyl cyclase
(C) inhibition of guanylyl cyclase
(D) stimulation of guanylyl cyclase
(E) inhibition of phosphodiesterase, type III